Recent Quotes (30 days)

You have no recent quotes
chg | %

Dechra Pharmaceuticals plc news

   Watch this stock
Showing stories 1 - 10 of about 77   

Articles published

DPH 1,019.00 +16.00 (1.60%)
price chart
Analysts Set Dechra Pharmaceuticals plc Target Price at $803.49 (LON:DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has been given a consensus rating of �Buy� by the three ratings firms that are presently covering the company, Stock Ratings News reports.
3 Fast-Growing Pharmaceuticals Set To Outperform: Shire PLC, BTG plc and ...
However, I'm more interested in BTG and Dechra, which both occupy the FTSE 250 index. Yet BTG is around a ninth the size of Shire, and Dechra is around one thirty eighth the size of Shire, so we can pick from have a good spread of market capitalisations.
Dechra Pharmaceuticals plc Stock Rating Reaffirmed by N+1 Singer (DPH)
Dechra Pharmaceuticals plc (LON:DPH)'s stock had its �hold� rating reiterated by analysts at N+1 Singer in a research report issued to clients and investors on Friday.
Dechra Pharmaceuticals plc (DPH) - Investment Analysts' Weekly Ratings Updates
2/27/2015 - Dechra Pharmaceuticals plc had its �no rating system� rating reaffirmed by analysts at Edison Investment Research.
Dechra Pharmaceuticals plc Given "Hold" Rating at N+1 Singer (DPH)  Intercooler
Dechra Pharmaceuticals plc Earns "Hold" Rating from N+1 Singer (DPH)
Analysts at Edison Investment Research reiterated a no rating system rating and set a GBX 955 ($14.38) price target on shares of Dechra Pharmaceuticals plc in a research note on Friday, February 27th. Analysts at Numis Securities Ltd downgraded shares ...
Recent Research Analysts' Ratings Changes for Dechra Pharmaceuticals plc ...
2/27/2015 - Dechra Pharmaceuticals plc had its �no rating system� rating reaffirmed by analysts at Edison Investment Research.
PZ Cussons plc Receives Consensus Rating of "Hold" from Analysts ...  Mideast Time
Dechra Pharmaceuticals plc Price Target Raised to GBX 885 at N+1 Singer (DPH)
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) had its price target upped by N+1 Singer from GBX 783 ($12.04) to GBX 885 ($13.61) in a research note issued to investors on Monday.
Dechra Pharmaceuticals plc's Buy Rating Reaffirmed at Investec (DPH)  Ticker Report
Consort Medical plc Given "Buy" Rating at Canaccord Genuity (CSRT)  WKRB News
Investec Reaffirms Buy Rating for Dechra Pharmaceuticals plc (DPH)
Investec reaffirmed their buy rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a report released on Tuesday. Investec currently has a GBX 960 ($14.48) price objective on the stock.
Dechra Pharmaceuticals plc Given No Rating System Rating at Edison ...
Dechra Pharmaceuticals plc logo Edison Investment Research restated their no rating system rating on shares of Dechra Pharmaceuticals plc (LON:DPH) in a report released on Friday. Edison Investment Research currently has a GBX 955 ($14.69) price ...
Dechra Pharmaceuticals plc Receives GBX 803.49 Average PT from Analysts ...
Dechra Pharmaceuticals plc logo Dechra Pharmaceuticals plc (LON:DPH) has received a consensus rating of �Buy� from the nine ratings firms that are covering the company, American Banking News.